Birmingham, ALNCT06634459Now EnrollingIRB Ready

Pelvic Organ Prolapse Clinical Trial in Birmingham, AL

Access cutting-edge pelvic organ prolapse treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.

Sponsored by Medstar Health Research Institute

Quick Self-Assessment

See if you qualify for this Birmingham location

Preparing your pre-screening questions…

Expert Care in Birmingham

Access pelvic organ prolapse specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pelvic organ prolapse treatment provided free

Apply for This Birmingham Location

Check if you qualify for this pelvic organ prolapse clinical trial in Birmingham, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Birmingham

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Birmingham site if eligible
  4. 4Begin participation

About This Pelvic Organ Prolapse Study in Birmingham

This multi-centered, randomized controlled trial will evaluate the safety and efficacy of home use of the novel Reia System (RS), which includes the Reia pessary and applicator, compared to standard pessary care (Gellhorn or ring with/without support without knob) among women with stage II-IV pelvic organ prolapse (POP). A total of 200 participants will be recruited among pessary naïve patients who are symptomatic and choose a vaginal pessary for management of their POP from study sites specializing in Urogynecology and Reconstructive Pelvic Surgery (URPS). Participants will be assigned via 1:1 randomization using computer generated numbers in permutated groups of variable block sizes to either the intervention (the Reia System, RS) or standard pessary care (SPC) stratified by site. Participation in this trial will involve a total of four visits over six months. The primary outcome measure will be satisfaction measured at the six-month time point. Secondary outcomes will include validated surveys to assess quality of life, number of self-management events, ease/difficulty of pessary insertion/removal, importance of ability to self-manage pessary, and adverse events. Specific Aims Aim 1: To compare satisfaction with pessary use and management between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 2: To assess successful fitting, number of refitting visits, number of self-management events and continued pessary use over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 3: To compare ease/difficulty of pessary use and importance of ability to self-manage, as well as quality of life over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 4: To measure rates of adverse events and risk factors for adverse events over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary.

Sponsor: Medstar Health Research Institute

Who Can Participate

Inclusion Criteria

English-speaking natal females ≥ 18 years of age
Willing to self-maintain (insert/remove) pessary
Pessary naïve with Stage II-IV POP desiring conservative management with a pessary
Primary indication for use of pessary is treatment of pelvic organ prolapse

Exclusion Criteria

Primary indication for pessary use is for management of stress urinary incontinence
Prior mesh-augmented prolapse repair (i.e. transvaginal mesh, sacrocolpopexy)
Short vaginal length (TVL \< 8cm) or subjective vaginal narrowing
Vaginal fistula (e.g. rectovaginal, vesicovaginal or any type of fistula involving the vagina)
Vaginal, rectal or bladder malignancy
Genitourinary infection requiring treatment (See below 1)
Ongoing treatment for vaginal infections (e.g., chronic bacterial vaginosis) (See below 2)
Inflammatory bowel disease (Crohn's or ulcerative colitis)
Pelvic or anorectal chronic pain
Pelvic floor surgery within the past 6 months or planning to undergo pelvic floor surgery
Congenital malformation of the bladder, rectum or vagina
Pregnant or planning pregnancy in the next 6 months
Prior failure of pessary for POP
History of hydroureter, hydronephrosis, or impaired renal function secondary to prolapse
Patients with acute vaginal infections will be eligible for enrollment 2 weeks after completing treatment with resolution of symptoms
OK to be on prophylactic/suppressive therapy for HSV

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Birmingham?

Yes, this clinical trial (NCT06634459) has an active research site in Birmingham, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pelvic Organ Prolapse Treatment Options in Birmingham, AL

If you're searching for pelvic organ prolapse treatment options in Birmingham, AL, this clinical trial (NCT06634459) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pelvic organ prolapse specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pelvic organ prolapse clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Birmingham, AL

See all pulmonary embolism clinical trials recruiting in Birmingham — not just this study.

Browse Pulmonary Embolism Trials in Birmingham

Ready to Join in Birmingham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Birmingham, AL